NCT02974868 Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Subjects With Alopecia Areata Status COMPLETED Phase PHASE2
NCT02812342 Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants Status COMPLETED Phase PHASE2
NCT02691117 Topical Garlic Concentrate for Alopecia Areata in Children Status TERMINATED Phase PHASE3
NCT02684123 Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata Status COMPLETED Phase NA
NCT02684097 A Pilot Study of Tralokinumab in Subjects With Moderate to Severe Alopecia Areata Status COMPLETED Phase PHASE2
NCT02604888 Efficacy Study of a Cosmetic Lotion in the Treatment of Alopecia Areata in Males and Females Status UNKNOWN Phase NA
NCT02599129 A Study of Secukinumab for the Treatment of Alopecia Areata Status TERMINATED Phase PHASE2
NCT02557074 TREg Activation in the Treatment of the PELADE (Alopecia Areata) Status COMPLETED Phase PHASE3
NCT02553330 A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA) Status TERMINATED Phase PHASE2
NCT02350023 Comparison of Topical Latanoprost vs Topical Corticosteroid in Treatment of Localized Alopecia Areata Status COMPLETED Phase PHASE4
NCT02312882 Tofacitinib for the Treatment of Alopecia Areata and Its Variants Status COMPLETED Phase NA
NCT02299297 Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And Universalis Status COMPLETED Phase PHASE2
NCT02037191 The Efficiency Of The Methotrexate At Patients Affected By Grave Pelade Status COMPLETED Phase PHASE3
NCT02018042 An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areata Status COMPLETED Phase PHASE2
NCT01950780 Pilot Study to Evaluate the Efficacy of Ruxolitinib in Alopecia Areata Status COMPLETED Phase PHASE2
NCT01931644 At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions Status COMPLETED Phase N/A
NCT01917058 A Clinical Trial to Evaluate the Efficacy of Abatacept in Moderate to Severe Alopecia Areata Status WITHDRAWN Phase PHASE2